Skip to main navigation Skip to search Skip to main content

Phospho-Sulindac for Lung Cancer Treatment

Project: Research

Project Details

Description

DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer deaths, with a 5-year survival rate of
StatusFinished
Effective start/end date07/22/1406/30/21

Funding

  • National Cancer Institute: $1,829,994.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.